- OPD 9 AM – 6 PM · Emergency 24×7
- Mayur Nagar, N-11, CIDCO, Chhatrapati Sambhajinagar
Home › Hemato-oncology › Multiple Myeloma Treatment
Multiple myeloma is a type of blood cancer that develops in plasma cells, a type of white blood cell responsible for producing antibodies.
It affects the bone marrow and can cause problems such as bone damage, kidney complications, anaemia and an increased risk of infections.
Multiple myeloma treatment aims to control the growth of cancer cells, manage symptoms, prevent complications and improve quality of life. Treatment may involve a combination of medicines, including chemotherapy, targeted therapy, immunotherapy and steroids. Stem cell transplantation may also be considered for eligible patients. At Karnawat Cancer Hospital in Sambhajinagar, patients can consult an oncology specialist to understand their diagnosis and discuss suitable cancer treatment options based on their individual medical condition.
Multiple myeloma is a cancer that develops when plasma cells in the bone marrow become abnormal and multiply uncontrollably. These abnormal cells can accumulate in the bone marrow and produce abnormal proteins called monoclonal proteins or M proteins.
As abnormal plasma cells increase, they can interfere with the production of healthy blood cells and damage bones and other organs. The condition may cause bone pain, fatigue, anaemia, kidney problems and recurrent infections.
Multiple myeloma can develop gradually, and some people may not experience noticeable symptoms in the early stages. Treatment depends on the disease characteristics, symptoms and the patient’s overall health.
The symptoms of multiple myeloma can vary from person to person, depending on how the disease affects the body. Some people may experience persistent symptoms, while others may have few or no noticeable symptoms in the early stages. Common symptoms include persistent bone pain, particularly in the back, ribs or hips, fatigue and weakness caused by anaemia, frequent infections, weakened bones or fractures, increased thirst and frequent urination due to high calcium levels, nausea, loss of appetite, unexplained weight loss, kidney problems and numbness or tingling in the hands and feet. These symptoms can also occur with other medical conditions, so persistent or unexplained symptoms should be evaluated by a qualified healthcare professional.
Accurate diagnosis of multiple myeloma helps determine the right treatment. Doctors may use blood tests, urine tests, bone marrow examination and imaging studies.
Blood tests can detect abnormal proteins, anaemia, kidney problems and elevated calcium levels. Tests such as serum protein electrophoresis and free light chain testing help identify myeloma-related proteins.
Urine tests can detect abnormal proteins, including light chains produced by myeloma cells. They also help doctors assess kidney function and understand the extent of the disease.
Bone marrow aspiration and biopsy determine whether abnormal plasma cells are present in the bone marrow. These tests also assess the number and characteristics of these abnormal cells.
X-rays, CT scans, MRI, or PET-CT scans may be used to identify bone damage, lesions, fractures or other areas affected by multiple myeloma.
Genetic and chromosome tests identify specific changes in myeloma cells. These findings can help doctors assess disease risk, understand prognosis and plan the most appropriate treatment.
Multiple myeloma treatment depends on the patient’s condition and may include chemotherapy, targeted therapy, immunotherapy, corticosteroids or stem cell transplantation.
Chemotherapy uses medicines to destroy myeloma cells or slow their growth. It may be used as part of initial treatment or when the disease returns or does not respond adequately to previous therapy. The choice of medicines, dosage, combination, and treatment schedule depends on the patient's condition and overall treatment plan.
Targeted therapy uses medicines that act on specific proteins or biological processes involved in myeloma cell growth and survival. Proteasome inhibitors and monoclonal antibodies are commonly used targeted treatments. They may be combined with other medicines, depending on the patient's disease characteristics, previous treatments, treatment response, and overall health.
Immunotherapy helps the immune system recognise and attack myeloma cells. Certain medicines may be combined with other treatments to control multiple myeloma. Bispecific antibodies and CAR T-cell therapy may be considered for selected patients, particularly when the disease returns or becomes resistant to previous treatment. Suitability depends on individual factors.
Treatment commonly involves combinations of medicines that work in different ways. These may include proteasome inhibitors, immunomodulatory drugs, monoclonal antibodies, corticosteroids, and chemotherapy medicines. Examples include bortezomib, lenalidomide, daratumumab, and dexamethasone. The treating oncologist selects appropriate medicines, combinations, and treatment duration based on the patient's clinical condition.
Autologous stem cell transplantation may be recommended for selected patients with multiple myeloma. The process involves collecting and storing the patient's stem cells, giving high-dose chemotherapy, and then returning the stem cells to restore blood cell production. Eligibility depends on factors such as age, overall health, disease characteristics and treatment response.
Supportive care helps manage symptoms, prevent complications, and improve overall well-being during multiple myeloma treatment. Depending on individual needs, it may include managing bone pain, protecting bone health, preventing infections, treating anaemia, addressing kidney-related problems and providing nutritional or symptom-management support alongside cancer-directed treatment.
Choosing a cancer treatment hospital involves understanding the available diagnostic services, treatment options and supportive care. Multiple myeloma requires an individualised treatment plan because the disease can affect patients differently. Karnawat Cancer Hospital in Sambhajinagar provides cancer care and oncology consultations for patients seeking evaluation and treatment. Patients can discuss their diagnosis, test results and appropriate treatment options with the oncology team. If you are looking for a multiple myeloma treatment hospital in Sambhajinagar, an oncology consultation can help you understand the treatment options and the next steps based on your medical condition.
Multiple myeloma treatment may include a combination of chemotherapy, targeted therapy, immunotherapy and corticosteroids. Eligible patients may also undergo autologous stem cell transplantation. The treatment plan depends on the disease characteristics, symptoms and overall health.
Multiple myeloma is generally treated with a combination of medicines that target cancer cells in different ways. Treatment may involve an initial combination of drugs, followed by stem cell transplantation for eligible patients and maintenance therapy when appropriate. Patients with relapsed disease may require different treatment combinations.
Common side effects include fatigue, nausea, loss of appetite, low blood cell counts, infections, diarrhoea and nerve-related symptoms. The side effects depend on the medicines and treatment approach. Regular monitoring helps doctors manage treatment-related complications.
Medicines used for multiple myeloma include proteasome inhibitors such as bortezomib, immunomodulatory drugs such as lenalidomide, monoclonal antibodies such as daratumumab and corticosteroids such as dexamethasone. Doctors select medicines and combinations according to the patient’s diagnosis and treatment needs.
No. Stem cell transplantation is an option for selected patients, but it is not necessary or suitable for everyone. Doctors consider the patient’s health, disease characteristics and response to initial treatment before recommending it.
Multiple myeloma is generally not considered curable with current standard treatments. However, treatment can help achieve remission, control the disease and reduce symptoms. Some patients can maintain disease control for many years, depending on their individual condition and response to treatment.
No. Some patients with smouldering multiple myeloma who do not have active disease may be monitored regularly without immediate treatment. Active multiple myeloma generally requires treatment, especially when it causes symptoms or organ damage.
You should consult an oncologist if you have been diagnosed with multiple myeloma or have concerning symptoms such as persistent bone pain, unexplained fatigue, recurrent infections or abnormal blood test results. Early evaluation helps determine whether treatment is needed and which options may be appropriate.
This page is for general information and does not replace a consultation. Treatment is decided by your oncologist after reviewing your reports.
Emergency & I.C.U. 24×7 · OPD 9 AM – 6 PM
Karnawat Cancer Hospital provides hemato-oncology care for patients with blood cancers and related blood and bone marrow disorders.
Leukemia is a type of blood cancer that begins in the blood-forming tissues, mainly the bone marrow.
Lymphoma is a type of blood cancer that develops in the lymphatic system, which is an important part of the body’s immune system.
Stem cell and bone marrow transplantation is a specialised medical procedure used to treat certain blood cancers, bone marrow disorders and…
Consultations, second opinions and treatment planning. Emergency and I.C.U. care 24 hours a day.
Share your details and our team will call you to confirm a time.
